CDD-2110
CDD-2210 is a STK33 inhibitor, with a Kd of 0.1 nM and an IC50 of 38 nM. CDD-2210 has relatively weak inhibitory effects on off-target kinases, with IC50 values of 1209 nM for CLK1, 917 nM for CLK2, 544 nM for CLK4, and 746 nM for RET. CDD-2210 can be used for the study of contraception[1].
Product Specifications
CAS Number
3086535-49-8
Target
RET; STK33
Related Pathways
Cell Cycle/DNA Damage; Protein Tyrosine Kinase/RTK
Field of Research
Others
Smiles
O=C(N1CCC(C1)N2CCC(CC2)C(NC)=O)C3=CC4=C(NN=C4C#CC5=C(C6=CC=CC=C6)C=CC=C5)C=C3
Molecular Formula
C33H33N5O2
Molecular Weight
531.65
References & Citations
[1]Ku AF, et al. Reversible male contraception by targeted inhibition of serine/threonine kinase 33. Science. 2024 May 24;384 (6698) :885-890.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
orb2577804 100 µg
Monoamine Oxidase B/MAOB Rabbit Polyclonal Antibody (Biotin)
Sign In for Pricing
View Details 
MBS6326216-01 0.2 mL
NPFF, CT (NPFF, FMRFamide-related peptides, Neuropeptide SF, Neuropeptide FF, Neuropeptide AF) (APC)
Sign In for Pricing
View Details MBS6326216-02 5x 0.2 mL
NPFF, CT (NPFF, FMRFamide-related peptides, Neuropeptide SF, Neuropeptide FF, Neuropeptide AF) (APC)
Sign In for Pricing
View Details 
138246-AP 100 µL
Prostate Specific Antigen (Prostate-specific Antigen, PSA, APS, Gamma-seminoprotein, Kallikrein-3, KLK3, hK3, KLK2A1, P-30 Antigen, Seminin, Semenogelase) (AP) discontinued
Sign In for Pricing
View Details